Esperovax, INC.
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50120C00154
- Awardee
-
Esperovax Inc. UEI HM3MB3CDWMM6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $484,643
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Esperovax Award Notice · Posted Oct 2, 2020
- Contract value 100% obligated
- $484,643.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 20 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Plymouth, MI 48170, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$50,000 | |
| Supplemental Agreement for work within scope | -$72,137 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $606,780 |
About this award
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Esperovax Inc. a $484,643 firm fixed price definitive contract to develop host-directed therapeutic candidates for mitigating long-term effects of respiratory distress. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought proposals for candidates aiding long-term outcomes from lung injury through Area of Interest 12. Work will be performed in Plymouth, Michigan through February 2023. No subcontractors or set aside designations were identified. This award supports the Department's goal of developing medical countermeasures to strengthen national health security against disease threats.
Quick answers
Who was awarded contract 75A50120C00154?
75A50120C00154 was awarded to Esperovax Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 27, 2020.
How much is contract 75A50120C00154 worth?
The government has obligated $484,643 on 75A50120C00154.
Was contract 75A50120C00154 competed?
The extent of competition for 75A50120C00154 was full and open competition. The government received 20 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award